1
|
Nelson SE, Steuernagle J, Rotello L, Nyquist P, Suarez JI, Ziai W. COVID-19 and telehealth in the intensive care unit setting: a survey. BMC Health Serv Res 2022; 22:797. [PMID: 35725458 PMCID: PMC9208537 DOI: 10.1186/s12913-022-08197-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 06/15/2022] [Indexed: 12/25/2022] Open
Abstract
Background Coronavirus disease (COVID-19) has led to changes in how healthcare is delivered. Here, through the administration of surveys, we evaluated telehealth use and views in US intensive care units (ICUs) during the pandemic. Methods From June 2020 to July 2021, voluntary, electronic surveys were provided to ICU leaders of Johns Hopkins Medical Institution (JHMI) hospitals, members of the Neurocritical Care Society (NCS) who practice in the US, and Society of Critical Care Medicine (SCCM) members practicing adult medicine. Results Response rates to our survey were as follows: 18 of 22 (81.8%) JHMI-based ICU leaders, 22 of 2218 (1.0%) NCS members practicing in the US, and 136 of 13,047 (1.0%) SCCM members. COVID-19 patients were among those cared for in the ICUs of 77.7, 86.4, and 93.4% of respondents, respectively, in April 2020 (defined as the peak of the pandemic). Telehealth technologies were used by 88.9, 77.3, and 75.6% of respondents, respectively, following the start of COVID-19 while only 22.2, 31.8, and 43.7% utilized them prior. The most common telehealth technologies were virtual meeting software and telephone (with no video component). Provider, nurse, and patient communications with the patient’s family constituted the most frequent types of interactions utilizing telehealth. Most common reasons for telehealth use included providing an update on a patient’s condition and conducting a goals of care discussion. 93.8–100.0% of respondents found telehealth technologies valuable in managing patients. Technical issues were noted by 66.7, 50.0, and 63.4% of respondents, respectively. Conclusions Telehealth use increased greatly among respondents following the start of COVID-19. In US ICUs, telehealth technologies found diverse uses during the pandemic. Future studies are needed to confirm our findings. Supplementary Information The online version contains supplementary material available at 10.1186/s12913-022-08197-7.
Collapse
Affiliation(s)
- Sarah E Nelson
- Johns Hopkins University, 1800 Orleans St, Baltimore, MD, 21287, USA. .,Department of Neurosurgery and Neurology, Mount Sinai West, 1000 10th Avenue, New York, NY, 10019, USA.
| | - Jon Steuernagle
- Johns Hopkins University, 1800 Orleans St, Baltimore, MD, 21287, USA
| | - Leo Rotello
- Johns Hopkins University, 1800 Orleans St, Baltimore, MD, 21287, USA
| | - Paul Nyquist
- Johns Hopkins University, 1800 Orleans St, Baltimore, MD, 21287, USA
| | - Jose I Suarez
- Johns Hopkins University, 1800 Orleans St, Baltimore, MD, 21287, USA
| | - Wendy Ziai
- Johns Hopkins University, 1800 Orleans St, Baltimore, MD, 21287, USA
| |
Collapse
|
2
|
Lu J, Hou J, Liu KY, Parmar S, De La Fuente A, Andersson B, Yan C, Zhou D, Tan D, Ritchie D, Wu D, Shpall E, Laport GG, Li J, Hu J, Zhang LS, Wang M, Malhotra P, Jiang Q, Qin Y, Wong R, Champlin R, Issaragrisil S, Iyer S, Mathews V, Wang Y, Hu Y, Xiao Z, Shao Z, Rosengarten R, Steuernagle J, Xiao JH, Orlowski R, Chim CS. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China. Leuk Lymphoma 2016; 57:1534-8. [PMID: 26887657 DOI: 10.3109/10428194.2015.1135434] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physician education network, has initiated a detailed longitudinal study of physician knowledge and practice preferences in the Asia-Pacific sphere. The first dataset comes from a series of surveys answered by delegates at the APHCON Bridging The Gap (BTG) conference in Beijing in January, 2015. In this report we present our findings regarding diagnosis and treatment of multiple myeloma (MM). We aim to create a conduit for physicians in this region to share their experiences with the rest of the world, to identify areas of consensus and best practices, and to highlight opportunities for improvement in communication, education and patient care.
Collapse
Affiliation(s)
- Jin Lu
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Jian Hou
- b Shanghai Changzheng Hospital , Shanghai , China
| | - Kai-Yan Liu
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Simrit Parmar
- c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA
| | | | - Börje Andersson
- c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA
| | - ChenHua Yan
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Daobin Zhou
- e Peking Union Medical College Hospital , Beijing , China
| | - Daryl Tan
- f Singapore General Hospital, Singapore , Singapore
| | | | - Deipei Wu
- h First Affiliated Hospital of Soochow University , Jiangsu , China , Jiangsu Institute of Hematology
| | - Elizabeth Shpall
- c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA
| | | | - JianYong Li
- j First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital , Nanjing , China
| | - Jiong Hu
- k Ruijin Hospital , Shanghai , China
| | - Lian Sheng Zhang
- l Gansu Provincial Key Laboratory of Hematology , Lanzhou , China
| | - Michael Wang
- c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA
| | - Pankaj Malhotra
- m Post Graduate Institute of Medical Education and Research , Chandigarh , India
| | - Qian Jiang
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Yazhen Qin
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Raymond Wong
- n Prince of Wales Hospital, the Chinese University of Hong Kong , Hong Kong, China
| | - Richard Champlin
- c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA
| | | | | | - Vikram Mathews
- q Christian Medical College and Hospital , Vellore , India
| | - Yu Wang
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Yu Hu
- r Wuhan Union Hospital , Wuhan , China
| | - Zhijian Xiao
- s Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences , Tianjin , China
| | - Zonghong Shao
- t General Hospital of Tianjin Medical University , Tianjin , China
| | - Rafael Rosengarten
- u Baylor College of Medicine , Houston , TX , USA ;,v MDRing , Houston , TX , USA
| | - Jon Steuernagle
- v MDRing , Houston , TX , USA ;,w Johns Hopkins Medical Institute , Baltimore, MD , USA
| | - Jun Huang Xiao
- a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China
| | - Robert Orlowski
- c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA
| | | |
Collapse
|